Shareprice
01 Mar 2024

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2024

1 March, 2024 Notice of Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
28 February, 2024 FluoGuide A/S publishes year-end and annual report for the fiscal year 2023 News English Regulatory Listing Regulation Report Annual IR
FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year 2023. The...
23 February, 2024 FluoGuide A/S issues warrants to CFO News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark, 23 February 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...

2023

9 December, 2023 Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
Copenhagen, Denmark, 9 December 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that...
8 December, 2023 FluoGuide raises SEK 12 million through exercise of warrants News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
29 November, 2023 FluoGuide A/S publishes interim report for the period January – September 2023 News English Regulatory Listing Regulation Report Interim Q3 IR
Copenhagen, Denmark, 29 November 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
13 November, 2023 FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer News Corporate Action Other English Regulatory MAR IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a pioneer in the cutting-edge field...

Calendar &
upcoming reports


8-10 January 2024

SEB Nordic Seminar


28 February 2024

Økonomisk Ugebrev Life Science Investor Conference


28 February 2024

Year end report 2023

Show all posts